Global Autoimmune Polyglandular Syndrome Type 1 Market Propelled by Growing Diagnosis and Treatment Rates
The global autoimmune polyglandular syndrome type 1 market comprises products utilized in the diagnosis and treatment of autoimmune polyglandular syndrome type 1 (APS1), commonly known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). APS1 is a rare monogenic disease characterized by the early onset of chronic mucocutaneous candidiasis followed by the development of...
0 Comments
0 Shares
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)